Results 141 to 150 of about 3,723 (172)
Some of the next articles are maybe not open access.

Biological Activities and Clinical Potential of Ebselen

1990
Ebselen (2-pheny1–1,2-benzisoselenazol-3(2H)-one; Fig. 1) is a seleno-organic compound which exhibits catalytic GSH-dependent, hydroperoxide reducing properties, similar to the action of glutathione peroxidase (GSH-Px)1–3.
openaire   +2 more sources

Modeling the Mechanism of the Glutathione Peroxidase Mimic Ebselen

Inorganic Chemistry, 2011
Ebselen (1), the quintessential mimic of the antioxidant selenoenzyme glutathione peroxidase (GPx), is a potential chemopreventative for various diseases associated with oxidative stress. Density-functional theory (DFT) and solvent-assisted proton exchange (SAPE) are used to model the complex mechanism for scavenging of reactive oxygen species by 1 ...
Sonia, Antony, Craig A, Bayse
openaire   +2 more sources

Ebselen as a Glutathione Peroxidase Mimic and as a Scavenger of Peroxynitrite

1996
Publisher Summary The compound ebselen is considered capable of contributing to the antioxidant defense in tissues. Many of the biological properties of ebselen were explainable on the basis of its property as an enzyme mimic, carrying out the function of the selenoenzyme, GSH peroxidase (GPx), and of phospholipid hydroperoxide GSH peroxidase (PHGPx).
H, Sies, H, Masumoto
openaire   +2 more sources

Determination of Ebselen by HPLC: Validation and Application of the Method

Chromatographia, 2004
Ebselen is an organo-selenium, highly hydrophobic compound that exhibits glutathion peroxidase-like activity. It is now in phase III trials in Japan for investigating its effect on ischemic stroke. We have developed an HPLC method for the determination of Ebselen at ambient temperature and applied it to a patented tablet formulation.
Yilmaz, S, Yalcin, G
openaire   +3 more sources

Ebselen

Biochemical Pharmacology, 1992
Jon D. Gower   +5 more
openaire   +1 more source

Ebselen

Drugs of the Future, 1984
N. Dereu, E. Graf
openaire   +1 more source

Scavenging of hypochlorous acid by carvedilol and ebselen in vitro

General Pharmacology: The Vascular System, 1997
1. The antihypertensive drug carvedilol and the antiinflammatory selenoorganic compound ebselen were tested for their ability to react with the reactive oxygen species hypochlorous acid (HOCl) in vitro. 2. Carvedilol scavenges HOCl at a rate sufficient to protect a model molecule catalase against inactivation by HOCl. 3.
openaire   +2 more sources

Ebselen

Inpharma Weekly, 1998
openaire   +1 more source

Antioxidant Properties of Ebselen

2019
Noriko Noguchi, Etsuo Niki
openaire   +1 more source

Home - About - Disclaimer - Privacy